Pharmaceutical giant Sanofi looks to sell consumer health unit, sparks political uproar
France's Economy and Industry ministers, Antoine Armand and Marc Ferracci, are heading to Lisieux this Monday to visit the production sites of popular headache reliever Doliprane. The visit takes place after the maker of the pill,
Sanofi In Talks To Sell Controlling Stake In Consumer Healthcare Unit To Owner Of Morrisons
The full content of this article is only available to NamNews Subscribers. If you are an existing subscriber, please log in below. Any problems logging in, contact us here
Sanofi in talks to sell 50% stake in consumer health business to CD&R
Sanofi has entered into discussions with U.S. private equity firm Clayton Dubilier & Rice to sell a controlling 50% stake in its consumer health business Opella, the French pharmaceutical giant said on Friday.
Sanofi enters talks with private equity firm to sell controlling stake in consumer health unit Opella
With reports swirling about potential interest in Sanofi’s consumer health business, the French pharma has confirmed that a deal is indeed brewing. | Sanofi has entered negotiations with private equity outfit Clayton,
CD&R in talks to buy 50% stake in Sanofi’s consumer healthcare unit Opella
Clayton Dubilier & Rice (CD&R) has entered negotiations to acquire a 50 percent controlling stake in Sanofi’s consumer healthcare business Opella.
Sanofi may have found a buyer for its consumer health business
The French pharmaceutical giant said it’s in negotiations to sell a controlling stake of Opella to the private equity firm CD&R, in a deal that reportedly could be worth more than $16 billion.
Sanofi’s Hudson Nears Goal of Splitting Off Consumer Health Unit
Sanofi is nearing the sale of its consumer health business to Clayton Dubilier & Rice, a year after Chief Executive Officer Paul Hudson announced plans to split off the division to concentrate on developing innovative medicines.
Sanofi in talks to sell consumer healthcare business that makes Dulcolax
Sanofi on Friday said it’s in talks with the private equity firm CD&R to sell just over half of its consumer healthcare business, in a deal that could yield billions of dollars for the French drugmaker.
Sanofi in talks to sell 50% stake in consumer health business to US private equity firm
In France, pharmaceutical giant Sanofi has entered into talks to sell a controlling 50% stake in its consumer health business Opella to a US private equity firm. The sale is estimated at around 15 billion euros.
Sanofi in Talks With CD&R Over Consumer Health Spinoff
IS IT THE CONSUMER AND THE PHARMA UNITS GOING IN DIFFERENT DIRECTIONS? EXACTLY RIGHT. WE HAVE SEEN A WHOLE SERIES OF THESE DEALS. WE SAW IT GSK, NOVARTIS, PFIZER JJ HAVE ALL GOTTEN OUT OF THESE MASS-MARKET CONSUMER GOODS BUSINESSES SELLING OVER-THE-COUNTER THINGS LIKE TRUTH TASTE,
Sanofi in Talks With CD&R to Sell Consumer Health Unit Stake
Sanofi is in talks to sell a 50% controlling stake in its consumer health unit to CD&R. It is set to be one of the biggest deals this year, following similar moves by big pharma peers GSK Plc, Novartis AG,
The Pharma Letter3h
BRIEF—Sanofi in talks to sell 50% of Opella
French pharma major Sanofi revealed it has entered into negotiations with private equity firm Clayton Dubilier & Rice (CD&R) for the potential sale of a 50% controlling stake in Opella, its consumer ...
France seeks job guarantees from Sanofi over Doliprane painkiller production
PARIS (Reuters) -The French government needs guarantees from drugmaker Sanofi that production of its popular Doliprane ...
France to Formally Screen CD&R Purchase of Sanofi Unit: Figaro
The French government is looking at options including state-owned investment bank BPIfrance taking a stake in the consumer ...
devdiscourse1d
Global Health Updates: Transplant Tragedy, Pharma Deals, Legal Precedents, and Vaccine Challenges
Recent health news highlights include HIV transmission via organ transplants in Brazil, Sanofi discussing a sale of its ...
PE Hub3d
Arlington’s Matthew Altman sees healthcare onshoring opportunities; CD&R vies for Sanofi healthcare consumer business; Sports tech wins deals
Potential deal by Clayton Dubilier & Rice for a leading consumer healthcare business; Arlington Capital Partners’ Matthew ...